Crescentis Capital reports ₹7.82 crore June-quarter profit

Crescentis Capital reported ₹7.82 crore net profit after tax and exceptional items for the unaudited quarter ended June 30, 2026, compared with audited net losses in Fiscal 2026 and Fiscal 2025, while revenue from operations rose to ₹10.94 crore and net worth reached ₹83.92 crore.

How did Crescentis Capital's June-quarter earnings change?

Crescentis Capital's net profit after tax and exceptional items rose to ₹7.82 crore in the quarter ended June 30, 2026, from ₹3.35 crore in the quarter ended June 30, 2025. Revenue from operations more than doubled to ₹10.94 crore from ₹4.95 crore over the same year-on-year comparison.

Profit before tax and exceptional items was ₹9.62 crore for the June 2026 quarter, compared with ₹4.11 crore a year earlier. Basic and diluted earnings per share, or EPS, were ₹4.60 in June 2026, up from ₹2.77 in June 2025; the filing says prior-period EPS was recomputed for the rights issue dated July 15, 2025, and restated for its bonus element under Indian Accounting Standard 33.

How does the June profit compare with Crescentis Capital's full-year results?

Crescentis Capital's June-quarter profit contrasts with net losses in its two preceding audited financial years. It reported a net loss after tax and exceptional items of ₹2.53 crore in Fiscal 2026, following a ₹5.42 crore loss in Fiscal 2025, before reporting ₹7.82 crore of profit for the June 2026 quarter.

The change is also visible in revenue from operations and pre-tax results. Fiscal 2026 revenue from operations was ₹1.48 crore, versus negative ₹3.02 crore in Fiscal 2025, while the pre-tax loss before exceptional items narrowed to ₹3.20 crore from ₹5.82 crore. The June 2026 quarter's ₹10.94 crore of revenue was higher than the Fiscal 2026 full-year figure disclosed in the filing.

The annual figures show basic and diluted EPS moving from negative ₹4.48 in Fiscal 2025 to negative ₹1.57 in Fiscal 2026, before reaching positive ₹4.60 for the June 2026 quarter. The filing states that quarterly EPS is not annualised, so the ₹4.60 figure describes the reported quarter rather than an annual earnings forecast.

What happened to Crescentis Capital's net worth and per-share value?

Crescentis Capital's net worth rose to ₹83.92 crore at June 30, 2026, from ₹33.03 crore at June 30, 2025 and ₹76.04 crore at March 31, 2026. Reserves and surplus, excluding statutory reserve, were ₹59.13 crore at June 30, 2026, compared with ₹16.14 crore a year earlier and ₹52.82 crore at the end of Fiscal 2026.

Equity share capital stood at ₹17.01 crore at June 30, 2026, against ₹10.01 crore a year earlier. Net asset value, or NAV, per equity share, calculated as net worth divided by fully paid shares outstanding at the period end, increased to ₹49.33 from ₹33.01 in June 2025 and from ₹44.70 at March 31, 2026.

Return on net worth, or RoNW, was 39.10% for the June 2026 quarter, compared with 42.73% in the June 2025 quarter. Both quarterly ratios are annualised under the filing's methodology, whereas the reported full-year RoNW was negative 4.77% in Fiscal 2026 and negative 16.63% in Fiscal 2025.

What are Crescentis Capital's rights-issue terms and pricing disclosures?

Crescentis Capital's fund-raising committee resolved on October 29, 2026, to offer three rights equity shares for every five shares held at ₹78 per rights share, including a ₹68 premium. The proposed issue aggregates to ₹79.62 crore, against board authorisations on May 29, 2026, and September 30, 2026, to raise up to ₹80 crore through a rights issue.

The filing says the ₹78 issue price is 7.8 times the ₹10 face value per equity share and gives an ex-rights price of ₹94.34 per share under Regulation 10(4)(b) of the Securities and Exchange Board of India Takeover Regulations. It also describes the issue price as carrying a 22.77% discount to the BSE closing market price one trading day before the rights-price announcement and a 24.72% discount to the preceding 10-trading-day volume-weighted average price, or VWAP.

Crescentis Capital attributes its pricing approach to historical market performance, trading liquidity and industry benchmarks. In its qualitative rationale, it describes a dual-engine model of listed equity investments and a growing lending portfolio, and says lending operations commenced in Fiscal 2026 in micro, small and medium enterprises, renewable-energy financing and healthcare-ecosystem segments.

BSE granted in-principle approval for listing the rights shares through a letter dated October 23, 2026. Crescentis Capital says it will apply to BSE for trading approval for rights entitlements and, after allotment, final approval for listing and trading of the rights equity shares; the filing gives no assurance on sustained trading or post-listing prices.

Conclusion

Crescentis Capital's June 2026 quarter marked a change from the audited losses recorded in Fiscal 2026 and Fiscal 2025, with ₹7.82 crore of net profit, ₹10.94 crore of revenue from operations and net worth of ₹83.92 crore. The year-on-year comparison also shows higher profit, revenue, reserves and NAV per share, while annualised RoNW was below the June 2025 quarterly figure.

The next disclosed matter to watch is execution of the ₹79.62 crore rights issue at ₹78 per share, including BSE trading approval for rights entitlements and final listing and trading approval for allotted rights shares. The filing also identifies the lending portfolio, which began in Fiscal 2026, as part of Crescentis Capital's stated operating model, but provides no lending-book size or future earnings target.